Unlock instant, AI-driven research and patent intelligence for your innovation.

A liver cancer targeting gene expression element ag and its application

A gene expression and targeting technology, applied in gene therapy, recombinant DNA technology, DNA/RNA fragments, etc., can solve the problems of limited application, high cost of siRNA, unfavorable regulation of shRNA, etc., to block energy supply and inhibit proliferation. Effect

Inactive Publication Date: 2011-12-07
ZHEJIANG UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the cost of chemically synthesized siRNA is too high, and the expression of shRNA is not conducive to regulation, these factors greatly limit the application of this technology

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A liver cancer targeting gene expression element ag and its application
  • A liver cancer targeting gene expression element ag and its application
  • A liver cancer targeting gene expression element ag and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Cloning of Regulatory Sequences Expressed by Recombinant AFP Positive Cells

[0025] First retrieve the mRNA sequence of the human AFP gene from GenBank (GenBank accession number: NM_001134), and then obtain the genome sequence of the No. 4 chromosome of people including the AFP gene from GenBank through online genome comparison analysis method (GenBank accession number : NT_006216.14), and based on the AFP gene mRNA sequence, its 5' end was used as the start point of AFP gene transcription, and the primers were designed and synthesized according to its upstream genome sequence: 5'-AGA TCT CAG ATT GAA TTA TTTGCC TGT CA -3', Primer 2: 5'-GGA TCC TAG GAA GTT TTC GCA ATA ATAC-3', Primer 3: 5'-AGA TCT GCC CCA AAG AGC TCT GTG T-3' and Primer 4: 5'-GGATCC AAA TCA TGC TGA AAT TCT TTT ATA CTC-3', using the polymerase chain reaction (Polymerase Chain Reaction, PCR) to use the genomic DNA of human liver cancer cell SMMC7721 as a template, carry out nucleic acid amplification with...

Embodiment 2

[0028] Cloning of artificial microRNA against human GAPDH

[0029] The mRNA sequence of the human GAPDH gene was retrieved from GenBank (GenBank accession number: NM_002046), and the appropriate site on the mRNA sequence was analyzed using online software to determine the target of the artificial microRNA, and the synthetic primer 1: 5'-TGC TGT TGA was designed CAG TGA GCGCGC TCA TTT CCT GGT ATG ACA ATA GTG AAG CCA CAG ATG TA-3', Primer 2: 5'-TCC GAG GCA GTA GGC AAG CTC ATT TCC TGG TAT GAC AAT ACATCT GTG GCT TCA CTATT-3', Primer 3 : 5′-AGATCT GAT CCA AGA AGG TATATT GCT GTT GAC AGT GAG CG-3′ and primer 4: 5′-GGA TCC ATC GTA GCCCTT GAA GTC CGA GGC AGT AGG CA-3′. Primer 1 and primer 2 were firstly subjected to overlap extension PCR to obtain amplified product C of 97 bp, and then amplified product C was used as a template to perform PCR amplification with primer 3 and primer 4 to obtain amplified product D of 142 bp, see figure 2 , wherein lane 1 is DL2000DNALadder, lane 2 is a...

Embodiment 3

[0032] Construction of liver cancer targeting gene expression element AG and preparation of adenovirus vector

[0033] First construct the pDC312-BGHpA vector: cut the adenovirus shuttle plasmid pDC312 vector (Microbix, USA) with restriction endonuclease Xba I single enzyme, fill in with Klenow enzyme, and then use restriction endonuclease HindIII single enzyme cut , Remove the part between Xba I and HindIII (from HindIII, Sac I, Ecl136 II, Acc I, Sal I to Xba I), one end of the recovered part is a blunt end, and the other end is a HindIII sticky end. The pcDNA3.1 (+) vector (Invitrogen Company, U.S.) was double-digested with restriction endonucleases PvuII and HindIII, and the recovery included HindIII, Asp718, Kpn I, BamH I, BstXI, EcoR I, EcoRV, BstXI, Not I, Fragment of the Xho I, Xba I, Dra II, Apa I, and Pme I multiple cloning sites and the bovine growth factor gene polyadenylation signal (BGHpA) with a HindIII sticky end on one end and a blunt PvuII end on the other. T...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a liver cancer targeting gene expression element AG, which has the nucleotide sequence shown in SEQ ID No:1. After the expression element AG provided by the present invention is introduced into alpha-fetoprotein-positive tumor cells, it can express artificial microRNA targeting GAPDH in the cells, and effectively inhibit the expression of GAPDH in the cells, thereby affecting the metabolism of glucose in the cells and finally blocking The main energy supply in cells can specifically inhibit the proliferation of AFP-positive liver cancer cells, and can be used in the preparation of targeted gene therapy drugs for AFP-positive liver cancer.

Description

technical field [0001] The present invention belongs to biological technology, and relates to regulation of gene expression, in particular, relates to the design and preparation of a targeted gene expression element AG specific for alpha-fetoprotein-positive liver cancer and its specificity in alpha-fetoprotein-positive liver cancer cells. Expression and its products can effectively block the energy supply in liver cancer cells, making various biochemical reactions in the cells unable to proceed due to lack of energy, thereby achieving the effect of inhibiting cell growth and proliferation. The invention can be used to prepare targeted tumor gene therapy drugs. Background technique [0002] Malignant tumor is currently one of the main "killers" of human beings. With the change of people's lifestyle and environment in recent years, its incidence is on the rise. It has become the first cause of death in many cities and the second in rural areas. Liver cancer is one of the mos...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/11A61K48/00A61P35/00A61P1/16
Inventor 曹江贾振宇陈萍毛晨宇
Owner ZHEJIANG UNIV